Volume 27, Number 6—June 2021
Research Letter
Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020
Table
Characteristics of healthcare workers with severe acute respiratory syndrome coronavirus 2 reinfections, Brazil, 2020*
Characteristic | Healthcare worker |
|||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
Underlying conditions |
None |
Chronic bronchitis |
None |
None |
Hospitalized |
No |
No |
No |
No |
Symptoms | ||||
First infection | Fever, headache, chills, sneezing, coryza, and myalgia | Headache, cough, myalgia, odynophagy, coryza, diarrhea, and ageusia | Nasal congestion, coryza, cough, ageusia | Fever, headache, myalgia, coryza, dry cough, vomiting, and malaise |
Second infection |
Headache, nasal congestion, odynophagia, ageusia, and anosmia |
Cough, myalgia, odynophagia, anosmia, and diarrhea |
Odynophagia, sneezing, coryza, diarrhea, ageusia, and anosmia |
Odynophagia, dry cough, myalgia, malaise, coryza, and headache |
Cycle threshold values | ||||
First infection† | E gene: 35.24; N gene: 40.12 | E gene: 31.8 | E gene: 35.15 | E gene: 34.80; RdRp gene: 39.86 |
Second infection‡ |
E gene: 31.14; N gene: 31.3; RdRp gene: 32.58 |
E gene: 20.45; N gene: 20.52; RdRp gene: 22.65 |
E gene: 26.04; N gene: 26.88; RdRp gene: 28.40 |
E gene: 23.72; N gene: 23.48; RdRp gene: 25.67 |
Time between symptom onsets, d | 55 | 170 | 131 | 148 |
*E gene, envelope gene; N gene, nucleoprotein gene; RdRp gene, RNA dependent RNA polymerase gene. †Real-time quantitative reverse transcription PCR selective for the envelope gene (2). ‡Nucleic acid amplification test using the GeneFinder COVID-19 Plus RealAmp Kit (OSANG Healthcare Co. Ltd., http://www.osanghc.com) (3).
References
- Pan American Health Organization/World Health Organization. Interim guidelines for detecting cases of reinfection by SARS-CoV-2. Washington (DC): The Organizations; 2020.
- Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR [Erratum in: Euro Surveill. 2020;25: 20200409c; 2020;25:2007303]. Euro Surveill. 2020;25:
2000045 . DOIGoogle Scholar - Ong DSY, Claas ECJ, Breijer S, Vaessen N. Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection? J Clin Virol. 2020;132:
104632 . DOIPubMedGoogle Scholar - Harrington D, Kele B, Pereira S, Couto-Parada X, Riddell A, Forbes S, et al. Confirmed reinfection with SARS-CoV-2 variant VOC-202012/01. Clin Infect Dis. 2021;
ciab014 ; Epub ahead of print. DOIPubMedGoogle Scholar - Nonaka CKV, Franco MM, Gräf T, de Lorenzo Barcia CA, de Ávila Mendonça RN, de Sousa KAF, et al. Genomic evidence of SARS-CoV-2 reinfection involving E484K spike mutation, Brazil. Emerg Infect Dis. 2021;27:27. DOIPubMedGoogle Scholar
- Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5:1403–7. DOIPubMedGoogle Scholar
- Candido DS, Claro IM, de Jesus JG, Souza WM, Moreira FRR, Dellicour S, et al.; Brazil-UK Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE) Genomic Network. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020;369:1255–60. DOIPubMedGoogle Scholar
- Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116–21. DOIPubMedGoogle Scholar
- Kulkarni O, Narreddy S, Zaveri L, Kalal IG, Tallapaka KB, Sowpati DT. Evidence of SARS-CoV-2 reinfection without mutations in Spike protein. Clin Infect Dis. 2021;
ciab136 ; Epub ahead of print. DOIPubMedGoogle Scholar
1These authors contributed equally to this article.